Serum interleukin 15 levels in patients with seropositive myasthenia gravis do not correlate with disease severity.
Sign Up to like & getrecommendations! Published in 2018 at "Neurologia i neurochirurgia polska"
DOI: 10.1016/j.pjnns.2017.12.011
Abstract: AIM To assess interleukin 15 (IL-15) serum levels in patients with seropositive myasthenia gravis (MG); searching for potential relationship between IL-15 levels and clinical features such as gender, age at onset, clinical presentation or treatment… read more here.
Keywords: levels patients; serum levels; myasthenia gravis; seropositive myasthenia ... See more keywords